Comparing Intuitive Surgical (ISRG) and Its Rivals
Intuitive Surgical (NASDAQ: ISRG) is one of 82 public companies in the “Advanced Medical Equipment & Technology” industry, but how does it contrast to its peers? We will compare Intuitive Surgical to similar businesses based on the strength of its valuation, dividends, institutional ownership, earnings, risk, profitability and analyst recommendations.
This is a summary of recent ratings and target prices for Intuitive Surgical and its peers, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Intuitive Surgical Competitors||257||1820||3272||105||2.59|
Intuitive Surgical presently has a consensus price target of $139.91, suggesting a potential downside of 62.14%. As a group, “Advanced Medical Equipment & Technology” companies have a potential upside of 2.54%. Given Intuitive Surgical’s peers higher probable upside, analysts clearly believe Intuitive Surgical has less favorable growth aspects than its peers.
This table compares Intuitive Surgical and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Intuitive Surgical Competitors||-328.03%||-36.01%||-12.63%|
Institutional and Insider Ownership
31.4% of Intuitive Surgical shares are held by institutional investors. Comparatively, 51.0% of shares of all “Advanced Medical Equipment & Technology” companies are held by institutional investors. 2.2% of Intuitive Surgical shares are held by company insiders. Comparatively, 18.6% of shares of all “Advanced Medical Equipment & Technology” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Intuitive Surgical and its peers top-line revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Intuitive Surgical||$2.87 billion||$1.08 billion||47.75|
|Intuitive Surgical Competitors||$2.02 billion||$430.74 million||-66.96|
Intuitive Surgical has higher revenue and earnings than its peers. Intuitive Surgical is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Volatility & Risk
Intuitive Surgical has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Comparatively, Intuitive Surgical’s peers have a beta of 0.89, suggesting that their average share price is 11% less volatile than the S&P 500.
Intuitive Surgical beats its peers on 8 of the 13 factors compared.
About Intuitive Surgical
Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company’s instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.